Stay updated with breaking news from Uniqure. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com cut shares of uniQure (NASDAQ:QURE – Free Report) from a hold rating to a sell rating in a research note published on Tuesday. QURE has been the subject of a number of other reports. Wells Fargo & Company reduced their price target on shares of uniQure from $24.00 to $14.00 in a report on […] ....
UniQure (NASDAQ:QURE – Get Free Report) has been assigned a consensus recommendation of “Buy” from the nine analysts that are presently covering the firm, Marketbeat.com reports. Nine equities research analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokers that have issued a report on the stock in the […] ....
UniQure (NASDAQ:QURE – Free Report) – Equities researchers at HC Wainwright upped their Q3 2023 earnings estimates for uniQure in a note issued to investors on Thursday, August 3rd. HC Wainwright analyst P. Trucchio now anticipates that the biotechnology company will post earnings of ($1.34) per share for the quarter, up from their previous forecast […] ....
UniQure (NASDAQ:QURE – Free Report) had its price objective cut by Raymond James from $56.00 to $50.00 in a research report released on Wednesday morning, Benzinga reports. They currently have an outperform rating on the biotechnology company’s stock. QURE has been the topic of a number of other research reports. StockNews.com raised shares of uniQure […] ....
UniQure (NASDAQ:QURE – Free Report) had its price objective reduced by Royal Bank of Canada from $47.00 to $42.00 in a report issued on Wednesday, MarketBeat.com reports. Royal Bank of Canada currently has an outperform rating on the biotechnology company’s stock. Other equities analysts also recently issued reports about the stock. StockNews.com raised shares of […] ....